Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

Speakers

Loading
Emanuele Ostuni

Emanuele Ostuni

Head Of Europe, Cell And Gene Therapy , Novartis
Emanuele Ostuni is Head of Europe for Cell and Gene Therapies at Novartis Oncology, where he oversees the commercialization of this portfolio in Europe.
Emanuele is with Novartis since 2012. He joined the Sandoz Division with the Global Strategy Team, where he managed the collaborations with Novartis Pharmaceuticals and Alcon. He then became Head of Specialty and Hospital Franchises, Central/Eastern Europe, where he developed a specialty expansion strategy. Subsequently he served as Business Unit Head, Rx in Romania. In this role, he grew the team to drive the expansion into CNS, respiratory, and rheumatology franchises.
Prior to joining Novartis in Europe, he was based in the USA where he was Vice President of Business Development at Nano Terra, Engagement Manager at McKinsey & Co and a Senior Research Investigator at Surface Logix, where he helped to establish the company’s drug discovery platform.
Emanuele holds a PhD in Physical Chemistry from Harvard University and BS and MS degrees in chemistry from Georgetown University.
Emanuele Ostuni is an Italian citizen, who spent part of his childhood in Canton Bern where he attended high school in Hasliberg. Emanuele is married with two sons and lives in the Basel area.
Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd